Analysis of the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene in pseudohypoparathyroidism type 1b
| Autor: | M, Minagawa, T, Watanabe, Y, Kohno, H, Mochizuki, G N, Hendy, D, Goltzman, J H, White, T, Yasuda |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
Polymorphism Genetic Adolescent Base Sequence RNA Splicing Homozygote Molecular Sequence Data Restriction Mapping DNA Sequence Analysis DNA Polymerase Chain Reaction Blotting Southern Japan Pseudohypoparathyroidism Humans Receptors Parathyroid Hormone Female Child Promoter Regions Genetic Polymorphism Single-Stranded Conformational Receptor Parathyroid Hormone Type 1 |
| Zdroj: | The Journal of clinical endocrinology and metabolism. 86(3) |
| ISSN: | 0021-972X |
| Popis: | Hypocalcemia and hyperphosphatemia caused by PTH resistance are the only discernible abnormalities in pseudohypoparathyroidism type 1b (PHP-1b). Because of the selective resistance toward PTH, inactivating mutations in its receptor, the PTH/PTH-related peptide receptor (PTHR1), were thought to be responsible for PHP-1b. However, gene abnormalities responsible for PHP-1b have not been identified in the coding region and well conserved promoters (P1 and P2) of the PTHR1 gene. The purpose of the present study was to analyze the structure of the P3 promoter, the main promoter of the human PTHR1 gene in kidney, in patients with PHP-1b. Southern analysis of genomic DNA from lymphoblastoid cell lines of eight nonfamilial patients with PHP-1b revealed neither gross rearrangements nor methylation abnormalities in the P3 promoter region of the PTHR1 gene. Sequencing revealed no abnormalities in the P3 promoter region, although one patient was homozygous for an (AAAG)n polymorphic variant. In conclusion, despite the selective resistance toward PTH in the kidney, which mainly uses the PTHR1 P3 promoter, PHP-1b in eight cases is not associated with structural abnormalities in this promoter. This study also indicates that inactivation of the P3 promoter is not achieved by methylation as tested in patients' genomic DNA from lymphoblastoid cell lines. The influence of alterations in the polymorphic A-rich repeat sequence on promoter activity warrants further study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|